[Not Available].
Fiche publication
Date publication
juin 2016
Journal
Bulletin du cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr VIGNOT Stéphane
Tous les auteurs :
Thariat J, Vignot S
Lien Pubmed
Résumé
Oligometastic progression (or solitary metastases) can justify ablative treatment for metastatic treatment. When such a strategy is discussed, it is important to notice that definition of oligometastases is not consensual both in terms of clinical presentation than on the biological basis. Does a specific biological background truly exist and are there markers that could predict for additional occult disease and its oligo or polymetastatic profile in individuals with demonstrated oligometastasis. This article provides a summary of the state of the art in this field and highlights some current areas of controversies.
Mots clés
Chirurgie des métastases, Metastasectomy, Oligometastasis, Oligométastase, Oligoprogression, Radiothérapie, Stereotactic radiotherapy, stéréotaxique
Référence
Bull Cancer. 2016 06;103(6 Suppl 1):S48-54